Get the full picture
Sign in to uncover key details.
Cour
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
710 Clark St, Evanston, Illinois, 60201,...Website
www.courpharma.comRevenue
$14.8 MillionIndustry
About Cour
Cour is a clinical-stage biotechnology company founded in 2015 and headquartered in Evanston, Illinois, developing targeted therapies to treat autoimmune and inflammatory diseases. The company leverages a proprietary antigen-specific immune tolerance platform designed to reprogram the immune system and address the underlying mechanisms of immune-mediated conditions. Cour's pipeline targets multiple autoimmune disorders including Type 1 Diabetes, Myasthenia Gravis, and Primary Biliary Cholangitis, with disease-modifying therapies intended to restore immune balance and preserve normal immune function. Operating in the biotechnology and pharmaceutical sectors, the company conducts research and development alongside pilot manufacturing operations.Explore more
Cour Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cour
Compare insights from companies similar to Cour, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cour Tech Stack
A closer look at the technologies used by Cour
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Cour
Sign Up For FreeTo access detailed company insights
Cour is a clinical-stage biotechnology company founded in 2015 and headquartered in Evanston, Illinois, developing targeted therapies to treat autoimmune and inflammatory diseases. The company leverages a proprietary antigen-specific immune tolerance platform designed to reprogram the immune system and address the underlying mechanisms of immune-me... Read More
